Search

everythinglearnresearchcommunity

for

Search:↓

Classifying alopecia helps diagnose and treat different types of hair loss accurately.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

The document discusses a condition causing hair loss after surgery and a type of rosacea affecting the nose, with treatments including surgery and laser therapy.

Early diagnosis and aggressive treatment are important for managing scarring alopecia; hair transplantation's effectiveness is uncertain.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

No treatment reliably changes Alopecia Areata's course; reassurance and possibly a wig are recommended.

Haloperidol effectively treated hemiballismus, but spontaneous improvement wasn't ruled out; rapid weight loss can cause hair loss with good regrowth chances.

The AI model somewhat predicts lymph node status in melanoma patients using skin sample images.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

Enemas can cause septicemia in elderly men with prostate infections.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Eating disorders like anorexia and bulimia cause skin problems, and dermatologists can help detect these disorders early for better treatment outcomes.

Both estrogens and androgens are important for health in both males and females.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.